Many patients with hypertension are also suffering from Type II Diabetes Mellitus (TIIDM). Different studies argued the fact that if these patients can use Hydrochlorothiazide (HCTZ) group or not to treat hypertension as these diuretics are accused of with diuretic-induced diabetes especially Chlorthalidone and Bendroflumethiazide. As nothing is definite yet; in this paper, we are jotting down a new theory. In other words, we are seeking to study HCTZ interactions with sulfonylurea receptor Kir 6.2\SUR1 considering the chemical fact that HCTZ is also sulfonamide derivates like sulfonylurea drugs which are hypoglycemic agents used in the treatment of TIIDM. Therefore, we have studied in-silico 12 HCTZ compounds' interactions with the binding site of sulfonylurea in its receptor Kir6.2\SUR1. Then, we compared the results to the interactions of Glibenclamide (GBM); a sulfonylurea agent, with the named receptor. As a result, three compounds of this family (Chlorthalidone 1-1, Bendroflumethiazide 4-1, Metolazone 6-1) had bound to Kir6.2\SUR1 receptor in the same binding site of GBM. The rest members were almost close to the GBM binding site. These findings may explain the adverse effect that chlorthalidone and Bendroflumethiazide are accused of with. We suggest that they are agonists for Kir6.1\SUR1 receptor, which results in decreasing insulin secretion from the pancreas which consequences with hyper-glycemia. On the other hand, our results confirm that developing new anti-hyperglycemia agents from HCTZ as a lead compound is also possible and promising.
INTRODUCTION
Many patients with hypertension are also suffering from Type II Diabetes Mellitus (TIIDM). Different studies argued the fact if these patients can use Hydrochlorothiazide (HCTZ) group or not treat hypertension as these diuretics are accused of with the adverse effect diuretic-induced diabetes. 1 However, this effect is not definite yet as different factors play a role in it. [1] [2] Researchers have resulted with those patients taking HCTZ who have Angiotensin Converter Enzyme ACE 4656 GG genotype will not suffer from diabetes, whereas patients with ACE 4565 hetero-type will. 1 Other studies have found a correlation between Hypokalemia and Hypoglycemia induced by HCTZ. Yet, other study casts doubt on it. 3 In addition, though HCTZs play an effective role in hypertension treatment, 4 and there are many pharmaceutical combinations between them and other anti-hypertension agents 5 ; however, other papers confirmed that HCTZ initiate the onset of diabetes independently from B-blockers, or other anti hypertension agents. 6 On the other hand, there are recommendations to use HCTZ with diabetic patients but in low dose to treat hypertension in these cases. 7 However, another study proved that people taking HCTZs to avoid kidney stones incidences did not suffer from diabetes. 8 As none of these perspectives is definite yet, and diureticinduced diabetes effect is still in debates; in this paper, we are suggesting a new theory for this adverse effect. This theory is based on in-silico detecting for HCTZ compounds and their interactions with sulfonylurea receptor Kir6.2\SUR1 considering the chemical fact that HCTZ is also sulfonamide derivates, Fig. 1 , like the anti-hyperglycemia sulfonylurea drugs. 
METHODS
Thiazide compounds' structures were obtained from Pubchem.com database. (Fig 2) Kir 6.2\SUR1 PDB ID used in this research was 6BAA. It was uploaded from Protein Data Bank database. [10] [11] Autodock 4.2.1 software was used for the rigid docking process in default settings. PyMol, Chimera, PLIP and LigPlot+ were used for virtual screening and interactions' analyzing. Validation of the software was done by re-docking in the rigid mode the isolated GBM from its crystal structure with its receptor. As four Glibenclamide (GBM) molecules located in the chains (E-H) of the receptor Kir6.2\SUR1, we have worked only on chain F. The binding site residues were obtained from PDB database. 10 And,each compound of HCTZ was docked with the binding site in the named chain. Scoring function used was binding energy in addition to the study of the binding sites' interactions and the number of complexes indicated in the same pockets out of 10 for each molecule. 
RESULTS AND DISCUSSION
As researchers can see in Table 1 , we have studied the twelve HCTZ compounds' interactions with Glibenclamide (GBM) binding site in the sulfonylurea receptor Kir 6.2\SUR1. (Table 3) . Superimposing the interacted complexes for the rest 9 compounds' conformations with Kir6.2\SUR1 is presented in Fig 3. There are 8 compounds in one pocket, and the last member which is Clopamide locates in the different site.
These differences between GBM and HCTZs bindings are probably because of the thiazide group which is responsible for the affinity to other residues than the ones that GBM binds to (Fig 4) . Therefore, The last presented findings in Fig 4 can be a cornerstone for developers in drug discovery to use HCTZs as lead compounds to discover new anti-hyperglycemia agents by applying chemical modifications like lengthening R moieties from sulfonylurea group or thiazide group as the pocket they bind to is too close to GBM one (Fig 5) . 
Figure 5
Superimposing between GBM pocket and the 9 HCTZ pockets. GBM is in magenta colour.
CONCLUSION
To encourage developing new HCTZ derivatives treat not only hypertension but also TIIDM in patients who are suffering from the two diseases, we have proved in this manuscript the interaction of 12 HCTZs with Glibenclamide (GBM) receptor Kir6.2\SUR1.
Chlorthalidone, Bendroflumethiazide, and Metolazone bind to the same pocket as GBM, while the other members bind to a close binding site to GBM pocket. These results add a new explanation of why these Chlorthalidone and Bendroflumethiazide are most accused of diuretic-induced-diabetes adverse effect among HCTZs medications. On the other hand, we have discovered a new preferable binding site for HCTZs that may be a cornerstone for developing new anti-hyperglycemia agents starting with HCTZs as lead compounds.
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